Osteopathic Manipulative Treatment in 564 Children with Congenital Heart Disease: A Project Report

Marco Petracca1,2,3, Matteo Turinetto1,4, Paola Sciomachen1

  • 1Registry of Osteopaths of Italy, 20149 Milan, Italy.

PubMed

Insights

Osteopathic manipulative treatment (OMT) significantly reduced pain and somatic dysfunction in hospitalized pediatric cardiac patients. This humanitarian project found OMT to be a safe and feasible adjunctive therapy for improving recovery outcomes.

Area of Science:

  • Pediatric Cardiology
  • Integrative Medicine
  • Osteopathic Manipulative Treatment

Background:

  • Congenital heart diseases (CHDs) are prevalent, necessitating improved pediatric patient quality of life and perioperative outcomes.
  • Multidisciplinary rehabilitation, including osteopathic care, is increasingly vital for pediatric cardiac surgery recovery.
  • Osteopathic manipulative treatment (OMT) offers manual techniques and lifestyle guidance to manage postoperative pain and enhance recovery.

Purpose of the Study:

  • To evaluate the impact of OMT on pain and somatic dysfunctions in hospitalized pediatric patients undergoing cardiac surgery.
  • To assess the safety and feasibility of OMT within a humanitarian volunteer project context.

Main Methods:

  • Retrospective descriptive study design analyzing patient records from October 2023 to March 2024.
  • Inclusion of 564 pediatric patients (0-18 years) undergoing cardiac surgery.
  • Pain assessment using validated scales (FLACC, Wong-Baker, NRS) at pre-surgery, post-surgery, and pre-discharge; somatic dysfunctions classified using ICD-10 M99 codes.

Main Results:

  • Significant reductions in pain scores were observed from Intensive Care Unit to postoperative ward (p < 0.001).
  • Somatic dysfunction severity significantly decreased across hospitalization phases (p < 0.001), with thoracic region and rib cage most affected.
  • Osteopathic manipulative treatment (OMT) was found to be safe, with no reported adverse events.

Conclusions:

  • OMT is a safe and feasible adjunctive therapy for pediatric patients with congenital heart disease undergoing surgery.
  • The study demonstrated decreases in pain and somatic dysfunction, supporting OMT's role in recovery.
  • Future research should focus on prospective, multicenter studies with control groups to establish causality and assess long-term outcomes.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
365
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
420
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
568
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
327
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
956
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
386